Sex Differences in Colorectal Cancer Survival: Population-Based Analysis of 164,996 Colorectal Cancer Patients in Germany
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Risk of colorectal cancer (CRC) is considerably higher in men compared to women; however, there is inconclusive evidence of sex differences in CRC prognosis. We aimed to assess and explain sex differences in 5-year relative survival using standard and model-based period analysis among 164,996 patients diagnosed with CRC from 1997 to 2006 and reported to 11 German cancer registries covering a population of 33 million inhabitants. Age-adjusted 5-year relative survival was higher in women (64.5% vs. 61.9%, P<0.0001). A substantial survival advantage of women was confirmed in multivariate analysis after adjusting for CRC stage and subsite in subjects under 65 years of age (relative excess risk, RER 0.86, 95% CI 0.82-0.90), but not in older subjects (RER 1.01, 95% CI 0.98-1.04); this pattern was similar in the 1st and in the 2nd to 5th year after diagnosis. The survival advantage of women varied by CRC stage and age and was most pronounced for localized disease (RERs 0.59-0.88 in various age subgroups) and in patients under 45 years of age (RERs 0.59, 0.72 and 0.76 in patients with localized, regional or advanced disease, respectively). On the contrary, sex differences in survival did not vary by location of CRC. In conclusion, our large population-based study confirmed a survival advantage of female compared to male CRC patients, most notably in young and middle aged patients and patients with localized disease. The effect of sex hormones, either endogenous or through hormonal replacement therapy, might be the most plausible explanation for the observed patterns.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,805
Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data
Verdecchia, A., Francisci, S., Brenner, H., Gatta, G., Micheli, A., Mangone, L., & Kunkler, I. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70246-2 · Cited by 1,285 · cited 1×
“[25,26,27]).”
Self-citationColeman, M., Forman, D., Bryant, H., Butler, J., Rachet, B., Maringe, C., Nur, U., Tracey, E., Coory, M., Hatcher, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62231-3 · Cited by 1,114
Regression models for relative survival
Dickman, P. W., Sloggett, A., Hills, M., & Hakulinen, T. (2004) · Statistics in Medicine · doi:10.1002/sim.1597 · Cited by 792 · cited 1×
“Model-based period analysis was also used to perform multivariate analysis [29].”
MethodEstrogen plus Progestin and Colorectal Cancer in Postmenopausal Women
Chlebowski, R. T., Wactawski-Wende, J., Ritenbaugh, C., Hubbell, F. A., Ascensao, J., Rodabough, R. J., Rosenberg, C. A., Taylor, V. M., Harris, R., Chen, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032071 · Cited by 669
Standard cancer patient population for age standardising survival ratios
Corazziari, I., Quinn, M., & Capocaccia, R. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.07.002 · Cited by 589 · cited 1×
“[21].”
Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis
Grodstein, F., Newcomb, P. A., & Stampfer, M. J. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00063-7 · Cited by 584 · cited 1×
“Women using HRT were shown to be at lower risk of CRC in a metaanalysis of 18 epidemiologic studies [35] and in a randomized trial [36].”
BackgroundIs There a Difference in Survival between Right- versus Left-Sided Colon Cancers?
Meguid, R. A., Slidell, M. B., Wolfgang, C. L., Chang, D. C., & Ahuja, N. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0015-y · Cited by 546 · cited 1×
“colon among women [13]; this was reported to be a rather unfavourable prognostic factor [14,15].”
BackgroundPeriod analysis for ‘up-to-date’ cancer survival data
Brenner, H., Gefeller, O., & Hakulinen, T. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.10.013 · Cited by 309 · cited 1×
“Period analysis [22] was employed to provide the most up-to-date estimates of 5-year relative survival.”
MethodSelf-citationThe advantage of women in cancer survival: An analysis of EUROCARE-4 data
Micheli, A., Ciampichini, R., Oberaigner, W., Ciccolallo, L., de Vries, E., Izarzugaza, I., Zambon, P., Gatta, G., & De Angelis, R. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.11.008 · Cited by 284 · cited 1×
“However, no comparison was provided adjusting for strong prognostic factors, such as CRC stage and subsite [31].”
BackgroundEfficacy of a Nationwide Screening Colonoscopy Program for Colorectal Cancer
Pox, C. P., Altenhofen, L., Brenner, H., Theilmeier, A., Stillfried, D. V., & Schmiegel, W. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.022 · Cited by 281 · cited 1×
“Participation rates have been higher in women than in men for both FOBT and screening colonoscopy, especially in younger age groups, which may have contributed to a higher proportion of early stages and better prognosis [10,11].”
BackgroundSelf-citationGender differences in colorectal cancer: implications for age at initiation of screening
Brenner, H., Hoffmeister, M., Arndt, V, & Haug, U. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603628 · Cited by 239 · cited 1×
“In most countries, incidence and mortality rates are considerably higher in men than in women [2].”
BackgroundSelf-citationCancer Causes Cardiac Atrophy and Autophagy in a Sexually Dimorphic Manner
Cosper, P. F., & Leinwand, L. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3145 · Cited by 214
Oral contraceptives and colorectal cancer risk: a meta-analysis
Fernandez, E., Vecchia, C. L., Balducci, A., Chatenoud, L., Franceschi, S., & Negri, E. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1622 · Cited by 212 · cited 1×
“This effect is not limited to endogenous hormones, as use of oral contraceptives [34] and postmenopausal hormonal replacement therapy (HRT) seem to also protect women from CRC.”
BackgroundGender Disparities in Metastatic Colorectal Cancer Survival
Hendifar, A., Yang, D., Lenz, F., Lurje, G., Pohl, A., Lenz, C., Ning, Y., Zhang, W., & Lenz, H.-J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0877 · Cited by 206 · cited 3×
“Whereas younger women exhibited better survival than younger men, an opposite pattern was seen among older patients [7,8].”
BackgroundResultUp-to-Date Long-Term Survival Curves of Patients With Cancer by Period Analysis
Brenner, H., & Hakulinen, T. R. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.826 · Cited by 184 · cited 1×
“Extensive empirical evaluations have shown that period analysis provides 5-year survival estimates that are very close to 5-year survival later observed for the patients diagnosed within the period of investigation [23,24] and is now widely used in cancer registry based survival analyses (e.”
BackgroundSelf-citationBrenner, H. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.2.456 · Cited by 168 · cited 1×
“Extensive empirical evaluations have shown that period analysis provides 5-year survival estimates that are very close to 5-year survival later observed for the patients diagnosed within the period of investigation [23,24] and is now widely used in cancer registry based survival analyses (e.”
BackgroundSelf-citationHenson, D. E., & Ries, L. A. (1995) · Cancer · doi:10.1002/1097-0142(19951115)76:10<1687::aid-cncr2820761002>3.0.co;2-i · Cited by 158
Male gender adversely affects survival following surgery for colorectal cancer
McArdle, C. S., McMillan, D. C., & Hole, D. J. (2003) · British journal of surgery · doi:10.1002/bjs.4098 · Cited by 143 · cited 3×
“Lower survival may also be associated with an ongoing inflammatory response, with elevated C-reactive protein, which is seen more often in males [42] and which reflect an increased number of deaths from cardiovascular diseases mainly in men [4,43].”
BackgroundResultSex differences in epidemiological, clinical and pathological characteristics of colorectal cancer
Koo, J. H., & Leong, R. W. L. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05992.x · Cited by 141 · cited 3×
“This estimate is therefore usually accompanied by cancer-specific survival; however, inaccurate classification of the cause of death may still confound the results [6].”
BackgroundResultPredictors of proximal vs. distal colorectal cancers
Gonzalez, E. C., Roetzheim, R. G., Ferrante, J. M., & Campbell, R. (2001) · Diseases of the Colon & Rectum · doi:10.1007/bf02234301 · Cited by 136 · cited 1×
“colon among women [13]; this was reported to be a rather unfavourable prognostic factor [14,15].”
BackgroundGender differences in long-term survival of patients with colorectal cancer
Wichmann, M. W., Müller, C., Hornung, H.-M., Lau‐Werner, U., & Schildberg, F. W. (2001) · British journal of surgery · doi:10.1046/j.0007-1323.2001.01819.x · Cited by 133 · cited 5×
“Other studies reported higher survival in female patients for CRC stage I or IV only [5], or for stage II only [12].”
BackgroundResultInfluentialWong, N. D., Pio, J., Valencia, R., & Thakal, G. (2001) · Preventive Cardiology · doi:10.1111/j.1520-037x.2001.00570.x · Cited by 122 · cited 1×
“Lower survival may also be associated with an ongoing inflammatory response, with elevated C-reactive protein, which is seen more often in males [42] and which reflect an increased number of deaths from cardiovascular diseases mainly in men [4,43].”
BackgroundA computer program for period analysis of cancer patient survival
Brenner, H., Gefeller, O., & Hakulinen, T. R. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00003-5 · Cited by 110 · cited 1×
“3 (SAS Institute, Cary, NC), using a publicly available macro for period analysis [30] and its adaptation for modelled period analysis [28] and multivariate analysis.”
MethodSelf-citationSurvival from colorectal cancer in Germany in the early 21st century
the GEKID Cancer Survival Working Group, Májek, O., Gondos, Á., Jansen, L., Emrich, K., Holleczek, B., Katalinic, A., Nennecke, A., Eberle, A., & Brenner, H. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.189 · Cited by 104 · cited 1×
“colon among women [13]; this was reported to be a rather unfavourable prognostic factor [14,15].”
BackgroundSelf-citationGender Influences Treatment and Survival in Colorectal Cancer Surgery
Paulson, E. C., Wirtalla, C. J., Armstrong, K., & Mahmoud, N. N. (2009) · Diseases of the Colon & Rectum · doi:10.1007/dcr.0b013e3181beb42a · Cited by 102 · cited 3×
“Paulson and colleagues indeed showed that the survival advantage of women is limited to patients without adjuvant therapy [3].”
BackgroundResultImproved Survival in Young Women With Colorectal Cancer
Koo, J. H., Jalaludin, B. B., Wong, S. K. C., Kneebone, A. B., Connor, S. J., & Leong, R. W. L. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01779.x · Cited by 91 · cited 3×
“Whereas younger women exhibited better survival than younger men, an opposite pattern was seen among older patients [7,8].”
ResultSurvival from common and rare cancers in Germany in the early 21st century
Hiripi, E., Gondos, Á., Emrich, K., Holleczek, B., Katalinic, A., Luttmann, S., Sirri, E., & Brenner, H. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr131 · Cited by 90 · cited 1×
“Full details were described elsewhere [16].”
Self-citationHormone Replacement Therapy and Survival After Colorectal Cancer Diagnosis
Chan, J. A.-W., Meyerhardt, J. A., Chan, A. T., Giovannucci, E. L., Colditz, G. A., & Fuchs, C. S. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.0580 · Cited by 84 · cited 1×
“Most notably, HRT use was also shown to extend survival in CRC patients [37,38,39].”
BackgroundSlattery, M. L., Anderson, K. E., Samowitz, W. S., Edwards, S. L., Curtin, K., Caan, B. J., & Potter, J. D. (1999) · Cancer Causes & Control · doi:10.1023/a:1008974215622 · Cited by 77 · cited 1×
“Most notably, HRT use was also shown to extend survival in CRC patients [37,38,39].”
BackgroundStock, C., & Brenner, H. (2010) · Endoscopy · doi:10.1055/s-0029-1244127 · Cited by 73 · cited 1×
“Offer and use of screening examinations vary between countries [9].”
BackgroundSelf-citationGatta, G., Zigon, G., Aareleid, T., Ardanáz, E., Bielska‐Lasota, M., Galcerán, J., Góźdź, S. S., Hakulinen, T. R., Martínez, C., Plesko, I., et al. (2010) · Acta Oncologica · doi:10.3109/02841861003782009 · Cited by 55 · cited 1×
“Similarly, we were not able to include information on a given CRC treatment, which is usually not available in population-based registries [45].”
BackgroundHormone replacement therapy in relation to survival in women diagnosed with colon cancer
Mandelson, M. T., Miglioretti, D. L., Newcomb, P. A., Harrison, R., & Potter, J. D. (2003) · Cancer Causes & Control · doi:10.1023/b:caco.0000007970.04094.76 · Cited by 49 · cited 1×
“Most notably, HRT use was also shown to extend survival in CRC patients [37,38,39].”
BackgroundPulte, D. D., Jansen, L., Gondos, Á., Emrich, K., Holleczek, B., Katalinic, A., Brenner, H., & the GEKID Cancer Survival Working Group (2014) · British Journal of Haematology · doi:10.1111/bjh.12722 · Cited by 24
Self-citationMenopausal hormone therapy in Germany
Heier, M., Moebus, S., Meisinger, C., Jöckel, K., Völzke, H., Döring, A., & Alte, D. (2008) · Maturitas · doi:10.1016/j.maturitas.2008.10.002 · Cited by 12
Cited by
Differences in cancer survival by sex: a population-based study using cancer registry data
Afshar, N., English, D. R., Thursfield, V., Mitchell, P. L., Te Marvelde, L., Farrugia, H., Giles, G. G., & Milne, R. L. (2018) · Cancer Causes & Control · doi:10.1007/s10552-018-1079-z · Cited by 255
Haldar, R., Ricon‐Becker, I., Radin, A., Gutman, M., Cole, S. W., Zmora, O., & Ben‐Eliyahu, S. (2020) · Cancer · doi:10.1002/cncr.32950 · Cited by 122
Jauhri, M., Bhatnagar, A., Gupta, S., BP, M., Minhas, S., Shokeen, Y., & Aggarwal, S. (2017) · Tumor Biology · doi:10.1177/1010428317692265 · Cited by 57
Metadata
- Authors
- Majek, O., Gondos, A., Jansen, L., Emrich, K., Holleczek, B., Katalinic, A., Nennecke, A., Eberle, A., Brenner, H., & the GEKID Cancer Survival Working Group
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-07-05
- Volume
- 8
- Issue
- 7
- Pages
- e68077
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2045736372
- Cited by
- 195
- References
- 36
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.